21 related articles for article (PubMed ID: 21932427)
1. Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
Maillet D; Allioli N; Péron J; Plesa A; Decaussin-Petrucci M; Tartas S; Sajous C; Ruffion A; Crouzet S; Freyer G; Vlaeminck-Guillem V
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885125
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression.
Lin X; Wang Y
Clin Transl Oncol; 2018 Nov; 20(11):1400-1407. PubMed ID: 29633185
[TBL] [Abstract][Full Text] [Related]
3. ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.
Hammarsten P; Winther J; Rudolfsson SH; Häggström J; Karalija A; Egevad L; Granfors T; Fowler CJ
PLoS One; 2014; 9(9):e105063. PubMed ID: 25215939
[TBL] [Abstract][Full Text] [Related]
4. Relative impact of 3- and 5-hydroxyl groups of cytosporone B on cancer cell viability.
Xia Z; Cao X; Rico-Bautista E; Yu J; Chen L; Chen J; Bobkov A; Wolf DA; Zhang XK; Dawson MI
Medchemcomm; 2013 Feb; 4(2):332-339. PubMed ID: 24795803
[TBL] [Abstract][Full Text] [Related]
5. Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.
Cipriano M; Häggström J; Hammarsten P; Fowler CJ
PLoS One; 2013; 8(6):e65798. PubMed ID: 23755281
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells.
Yang L; Egger M; Plattner R; Klocker H; Eder IE
Urology; 2011 Jun; 77(6):1508.e1-7. PubMed ID: 21624609
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
10. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
[TBL] [Abstract][Full Text] [Related]
11. ErbB2/Her-2 regulates the expression of Akt2 in prostate cancer cells.
Le Page C; Koumakpayi IH; Péant B; Delvoye N; Saad F; Mes-Masson AM
Prostate; 2012 May; 72(7):777-88. PubMed ID: 21932427
[TBL] [Abstract][Full Text] [Related]
12. Triangle of AKT2, miRNA, and Tumorigenesis in Different Cancers.
Honardoost M; Rad SMAH
Appl Biochem Biotechnol; 2018 Jun; 185(2):524-540. PubMed ID: 29199386
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
